Yves BOULOT

This profile gathers the share dealings of Yves BOULOT in Osmozis, where the filings describe the role as chief executive. In total, 12 filings cover trades dated from 31 August 2021 to 6 June 2024.

Both buying and selling appear: 9 purchases worth €364k, against 2 sales worth €5.8M. Taken together, the sales exceed the purchases by €5.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2024, the count stands at no purchases and 1 sale.

The median purchase comes to €41k. Clusters matter here: 8 out of 9 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 12 June 2024 came the latest disclosure, an open-market sale for €5.7M in Osmozis. The last purchase on record was published on 24 December 2021, which is 1,758 days ago. Filings reach the AMF feed a median of 6 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.